TY - JOUR
T1 - Intestinal Permeability and Dysbiosis in Female Patients with Recurrent Cystitis: A Pilot Study
AU - Graziani, Cristina
AU - Laterza, Lucrezia
AU - Talocco, Claudia
AU - Pizzoferrato, Marco
AU - Di Simone, Nicoletta
AU - D'Ippolito, Silvia
AU - Ricci, Caterina
AU - Gervasoni, Jacopo
AU - Persichilli, Silvia
AU - Del Chierico, Federica
AU - Marzano, Valeria
AU - Mortera, Stefano Levi
AU - Levi Mortera, Stefano
AU - Primiano, Aniello
AU - Poscia, Andrea
AU - Ponziani, Francesca Romana
AU - Putignani, Lorenza
AU - Urbani, Andrea
AU - Petito, Valentina
AU - Di Vincenzo, Federica
AU - Masi, Letizia
AU - Lopetuso, Loris Riccardo
AU - Cammarota, Giovanni
AU - Romualdi, Daniela
AU - Lanzone, Antonio
AU - Gasbarrini, Antonio
AU - Scaldaferri, Franco
PY - 2022
Y1 - 2022
N2 - : Recurrent cystitis (RC) is a common disease, especially in females. Anatomical, behavioral and genetic predisposing factors are associated with the ascending retrograde route, which often causes bladder infections. RC seems to be mainly caused by agents derived from the intestinal microbiota, and most frequently by Escherichia coli. Intestinal contiguity contributes to the etiopathogenesis of RC and an alteration in intestinal permeability could have a major role in RC. The aim of this pilot study is to assess gut microbiome dysbiosis and intestinal permeability in female patients with RC. Patients with RC (n = 16) were enrolled and compared with healthy female subjects (n = 15) and patients with chronic gastrointestinal (GI) disorders (n = 238). We calculated the Acute Cystitis Symptom Score/Urinary Tract Infection Symptom Assessment (ACSS/UTISA) and Gastrointestinal Symptom Rating Scale (GSRS) scores and evaluated intestinal permeability and the fecal microbiome in the first two cohorts. Patients with RC showed an increased prevalence of gastrointestinal symptoms compared with healthy controls. Of the patients with RC, 88% showed an increased intestinal permeability with reduced biodiversity of gut microbiota compared to healthy controls, and 68% of the RC patients had a final diagnosis of gastrointestinal disease. Similarly, GI patients reported a higher incidence of urinary symptoms with a diagnosis of RC in 20%. Gut barrier impairment seems to play a major role in the pathogenesis of RC. Further studies are necessary to elucidate the role of microbiota and intestinal permeability in urinary tract infections.
AB - : Recurrent cystitis (RC) is a common disease, especially in females. Anatomical, behavioral and genetic predisposing factors are associated with the ascending retrograde route, which often causes bladder infections. RC seems to be mainly caused by agents derived from the intestinal microbiota, and most frequently by Escherichia coli. Intestinal contiguity contributes to the etiopathogenesis of RC and an alteration in intestinal permeability could have a major role in RC. The aim of this pilot study is to assess gut microbiome dysbiosis and intestinal permeability in female patients with RC. Patients with RC (n = 16) were enrolled and compared with healthy female subjects (n = 15) and patients with chronic gastrointestinal (GI) disorders (n = 238). We calculated the Acute Cystitis Symptom Score/Urinary Tract Infection Symptom Assessment (ACSS/UTISA) and Gastrointestinal Symptom Rating Scale (GSRS) scores and evaluated intestinal permeability and the fecal microbiome in the first two cohorts. Patients with RC showed an increased prevalence of gastrointestinal symptoms compared with healthy controls. Of the patients with RC, 88% showed an increased intestinal permeability with reduced biodiversity of gut microbiota compared to healthy controls, and 68% of the RC patients had a final diagnosis of gastrointestinal disease. Similarly, GI patients reported a higher incidence of urinary symptoms with a diagnosis of RC in 20%. Gut barrier impairment seems to play a major role in the pathogenesis of RC. Further studies are necessary to elucidate the role of microbiota and intestinal permeability in urinary tract infections.
KW - dysbiosis
KW - gut microbiome
KW - intestinal permeability
KW - recurrent cystitis
KW - dysbiosis
KW - gut microbiome
KW - intestinal permeability
KW - recurrent cystitis
UR - http://hdl.handle.net/10807/229006
U2 - 10.3390/jpm12061005
DO - 10.3390/jpm12061005
M3 - Article
SN - 2075-4426
VL - 12
SP - 1005-N/A
JO - Journal of Personalized Medicine
JF - Journal of Personalized Medicine
ER -